MINSK, February 26 – RIA Novosti. Belarus has produced a trial batch of the Russian Sputnik V vaccine against coronavirus at its pharmaceutical plant, Minister of Health of the Republic Dmitry Pinevich said on Friday.
“A trial batch of the Russian vaccine has been produced,” Pinevich told reporters.
Your browser does not support this video format.
According to the minister, a trial batch of the vaccine has been produced on the basis of the republican enterprise Belmedpreparaty.
As Pinevich pointed out, this step is one of the most important results of strategic interaction between Belarus and Russia, as well as “a good start for scientific and medical cooperation.” “We have fulfilled the agreements of our presidents on joint counteraction to the spread of infection. Vaccination is now an integral factor in the fight against the epidemic process,” he said.
Pinevich stressed that for the Belarusian side, interaction with Russian colleagues in the medical field is strategic. “Our goal is to localize the production of this drug at the facilities of Belarusian enterprises,” added the head of the Ministry of Health of the republic.
On Monday, Russian President Vladimir Putin, at a meeting with his Belarusian counterpart Alexander Lukashenko in Sochi, said that Russia had transferred technology to Belarus for the production of Russian vaccines against coronavirus. On Wednesday, the Minister of Health of the Republic Dmitry Pinevich said that from March it is planned to bottle the Sputnik V vaccine at the capacities of pharmaceutical enterprises in Belarus, the volume of production will amount to 500 thousand doses per month.
On March 11, 2020, the World Health Organization declared the outbreak of the new coronavirus infection COVID-19 a pandemic. At the end of December, the Russian Direct Investment Fund (RDIF) announced that Belarus was the first after the Russian Federation to launch vaccination of the population against COVID-19 with the Russian Sputnik V vaccine.